Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: notyet who wrote (29675)	12/15/1999 4:25:00 PM
From: paul feldman	Read Replies (1) \| Respond to of 32384

OT- What happened to ISIP? Any thoughts,anybody?

To: notyet who wrote (29675)	12/15/1999 5:01:00 PM
From: Don S.Boller	Respond to of 32384

Go back and read Post 29597...that is not THAT FAR back!!

To: notyet who wrote (29675)	12/16/1999 7:46:00 AM
From: Steve	Read Replies (1) \| Respond to of 32384

check out this link. It may tell you what you want to know. lymphomafocus.org

To: notyet who wrote (29675)	12/18/1999 1:27:00 AM
From: Cheryl Galt	Respond to of 32384

> What is the current treatment for early-stage-CTLC? < I'll bite. Did you see the summary by Greg Rasp, radiation oncologist? beta.siliconinvestor.com Thanks, Greg. Please keep posting! There's nothing like real-life experience. Greg, could you tell us more about radiation treatment for early stage? How many days in a course? Likely side effects, tolerability at that stage? I read that taxanes act as a radiation sensitizer. Is Taxol or Taxotere plus radiation a possibility in early stage? --------------------- Also, there are guidelines put out at NIH's PDQ site. Besides trying to list all trials, so doctors and patients can find them, for each cancer type PDQ lists information for diagnosis, and the current treatment options, to guide decision making for people considering participation in clinical trials. The treatment standards are supported by a list of references, to journal reports and trial abstracts -- with dates as late as 1998, 1999. --------------------- For CTCL, here are the PDQ treatment standards for each phase - geared for physicians, with references: graylab.ac.uk I notice T Kuzel in the references. He's the lead investigator for the Ontac NHL trial, at ECOG. ------------------------------ (There's another list, geared for patients.) Perhaps Ligand's drugs will soon be in this list. They say it is updated monthly, by experts in the field. What do threaders and lurkers think of these treatment guidelines? Opinions anyone?? Cheryl ------------ PS - Here's the PDQ master list - graylab.ac.uk PPS - I'm curious. Does PDQ stand for "Pretty damn quick?"